Metagenomics Market

Market Definition:

At an estimated value of over USD 1.92 billion in 2023, the Global Metagenomics Market is predicted to thrive at a CAGR of 13.2% and valued at over USD 4.57 billion over the forecast year 2024-2030.  

Metagenomics encompasses various studies that use bioinformatic tools as well as sequencing technologies to attain valuable understanding on the varieties in the microbial community and microbes’ interaction in a community. These studies are making advancements across environmental & clinical microbiology, despite considerable barriers such as difficulty to enable a microbial culture, which is a method of multiplying microbial organisms. The technologies in metagenomics have allowed enhanced understanding of the microbial ecosystem along with the role of microbiology in the geochemical cycles. This has led to the understanding of the enormous microbial diversity for researchers, fueling the global market growth.

Market Dynamics and Trends:

The global metagenomics market is majorly driven by factors such as rise in investments across the development of bioinformatics platforms to support microbiome profiling & metagenomics and increasing applications of metagenomics across various fields such as identification of novel biocatalysts, personalized medicine, discovery of new antibiotics, and bioremediation. Also, funding as well as initiatives from private bodies and government for large-scale sequencing projects is anticipated to promote the growth of metagenomics market. However, lack of awareness about metagenomics is expected to hamper the market growth during the forecast period. Contradictorily, the adoption of cloud computing for data management in the field of metagenomics is expected to create opportunities, which will further propel the metagenomics market growth.

Market Segmentations and Scope of the Study:

The global metagenomics market share is segmented on the basis of offering, technology, sales channel, end user, and geography. On the basis of offering, the market is categorized into instruments, consumables, software, and services. The instruments segment is further classified into sequencers, sample preparation systems, and other instruments, where sequencers include short-read sequencers and long-read sequencers, while sample preparation systems include automated nucleic acid extractors and liquid handling robots. The consumables segment is divided into sample collection & stabilization products, nucleic acid extraction kits, library preparation kits, sequencing consumables, controls & reference standards, and other consumables. Library preparation kits are further segmented into amplicon kits, shotgun metagenomics kits, and targeted enrichment panels, while sequencing consumables include reagents & enzymes and flow cells. The software segment comprises run & control software, analysis software, databases & knowledge bases, LIMS & workflow management, and other software. Analysis software is further bifurcated into taxonomic profiling, metagenome assembly, and functional annotation. The services segment includes sequencing services, bioinformatics & analysis services, clinical testing & reporting services, consulting & contract research, and other services. Sequencing services are further segmented into amplicon sequencing, shotgun metagenomic sequencing, and long-read metagenomic sequencing.

On the basis of technology, the market is segmented into amplicon, shotgun metagenomics, long-read metagenomics, targeted capture, metatranscriptomics, and other technologies. On the basis of sales channel, the market is classified into direct sales, distributors & resellers, e-commerce, OEM partnership, and other sales channels. On the basis of end user, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, clinical diagnostics laboratories, public health laboratories, environmental & agricultural entities, food & beverage industry, contract research organizations (CROs), and others. Geographic fragmentation and analysis of each segment includes regions comprising North America, Europe, Asia-Pacific, and RoW.

Geographical Analysis:

In terms of geography, North America held major share of the market in 2019. This is due to the growing adoption of DNA sequencing across metagenomic applications in the region. In addition, surge in the implementation of novel sequencing technologies across the region has significantly contributed to its dominance. However, Asia pacific is expected to grow rapidly with increasing market size due to the significant patient pool as well as the rapidly evolving healthcare infrastructure in countries such as China, India, and Japan.

Competitive Landscape:

Maximum growth opportunities make the metagenomics market highly competitive. Some of the major players in the market are Thermo Fisher Scientific Inc., Illumina, Inc., QIAGEN N.V., Oxford Nanopore Technologies plc, Pacific Biosciences of California, Inc., MGI Tech Co., Ltd., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc., Revvity, Inc., Bio-Rad Laboratories, Inc., Eurofins Scientific SE, Novogene Co., Ltd., Azenta, Inc., Macrogen Inc., Zymo Research Corporation, Promega Corporation, Takara Bio Inc., New England Biolabs, Inc., Tecan Group Ltd., Eppendorf SE and many more. A number of developmental strategies have been adopted by companies in the past few years.

For instance, in February 2025, Illumina, Inc. unveiled a first-of-its-kind spatial transcriptomics technology designed to enable unbiased whole-transcriptome profiling with cellular resolution and high sensitivity. The platform, integrated with Illumina sequencers and the new Illumina Connected Multiomics software, supports large-scale spatial biology research and advanced multimodal data analysis.

In March 2025, Oxford Nanopore Technologies plc expanded its nanopore sequencing portfolio with enhanced real-time sequencing workflows and upgraded analytical capabilities for infectious disease surveillance, environmental monitoring, and metagenomics research. The company also strengthened its long-read sequencing platform with improved portability, scalability, and rapid data generation features for decentralized genomic analysis.

Key Benefits:

• The metagenomics market report provides the quantitative analysis of the current market and estimations through 2024-2030 that assists in identifying the prevailing market opportunities to capitalize on.

• The study comprises an extensive analysis of the metagenomics market trend including the current and future trends for depicting the prevalent investment pockets in the market

• The information related to key drivers, restraints and opportunities and their impact on the metagenomics market is provided in the report.

• The market share of the players in the global metagenomics market along with their competitive analysis.

• Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.

Key Market Segments:

By Offering

• Instruments

  • Sequencers

    • Short-Read Sequencers

    • Long-Read Sequencers

  • Sample Preparation Systems

    • Automated Nucleic Acid Extractors

    • Liquid Handling Robots

  • Other Instruments

• Consumables

  • Sample Collection & Stabilization

  • Nucleic Acid Extraction Kits

  • Library Preparation Kits

    • Amplicon Kits

    • Shotgun Metagenomics Kits

    • Targeted Enrichment Panels

  • Sequencing Consumables

    • Reagents & Enzymes

    • Flow Cells

  • Controls & Reference Standards

  • Other Consumables

• Software

  • Run & Control Software

  • Analysis Software

    • Taxonomic Profiling

    • Metagenome Assembly

    • Functional Annotation

  • Databases & Knowledge Bases

  • LIMS & Workflow Management

  • Other Software

• Services

  • Sequencing Services

    • Amplicon Sequencing

    • Shotgun Metagenomic Sequencing

    • Long-Read Metagenomic Sequencing

  • Bioinformatics & Analysis Services

  • Clinical Testing & Reporting Services

  • Consulting & Contract Research

  • Other Services

By Technology

• Amplicon

• Shotgun Metagenomics

• Long-Read Metagenomics

• Targeted Capture

• Metatranscriptomics

• Other

By Sales Channel

• Direct Sales

• Distributors & Resellers

• E-Commerce

• OEM Partnership

• Other

By End User

• Academic & Research Institutes

• Pharmaceutical & Biotechnology Companies

• Clinical Diagnostics Laboratories

• Public Health Laboratories

• Environmental & Agricultural Entities

• Food & Beverage Industry

• Contract Research Organizations (CROs)

• Other

By Geography

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • Italy

  • Spain

  • Netherlands

  • Rest of Europe

• Asia-Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • Taiwan

  • Vietnam

  • Rest of Asia-Pacific

• Rest of World

  • Latin America

  • Middle East

  • Africa

Key Players:

• Thermo Fisher Scientific Inc.

• Illumina, Inc.

• QIAGEN N.V.

• Oxford Nanopore Technologies plc

• Pacific Biosciences of California, Inc.

• MGI Tech Co., Ltd.

• F. Hoffmann-La Roche Ltd

• Agilent Technologies, Inc.

• Revvity, Inc.

• Bio-Rad Laboratories, Inc.

• Eurofins Scientific SE

• Novogene Co., Ltd.

• Azenta, Inc.

• Macrogen Inc.

• Zymo Research Corporation

• Promega Corporation

• Takara Bio Inc.

• New England Biolabs, Inc.

• Tecan Group Ltd.

• Eppendorf SE

Report Scope And Segmentation: